BioCentury
ARTICLE | Clinical News

Zyngenia preclinical data

March 18, 2013 7:00 AM UTC

In a mouse xenograft model of ovarian cancer, Zyngenia's trastuzumab-based bispecific zybody targeting angiopoietin 2 ( ANG2; ANGPT2) and epidermal growth factor receptor 2 ( EGFR2; HER2; ErbB2; ...